194 related articles for article (PubMed ID: 7525835)
1. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.
Boussiotis VA; Freeman GJ; Griffin JD; Gray GS; Gribben JG; Nadler LM
J Exp Med; 1994 Nov; 180(5):1665-73. PubMed ID: 7525835
[TBL] [Abstract][Full Text] [Related]
2. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.
Gribben JG; Guinan EC; Boussiotis VA; Ke XY; Linsley L; Sieff C; Gray GS; Freeman GJ; Nadler LM
Blood; 1996 Jun; 87(11):4887-93. PubMed ID: 8639863
[TBL] [Abstract][Full Text] [Related]
3. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.
Boussiotis VA; Freeman GJ; Gray G; Gribben J; Nadler LM
J Exp Med; 1993 Nov; 178(5):1753-63. PubMed ID: 7901318
[TBL] [Abstract][Full Text] [Related]
4. CD2 regulates responsiveness of activated T cells to interleukin 12.
Gollob JA; Li J; Reinherz EL; Ritz J
J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
[TBL] [Abstract][Full Text] [Related]
5. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
6. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
Taylor PA; Noelle RJ; Blazar BR
J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
[TBL] [Abstract][Full Text] [Related]
8. Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro.
Pawelec G; Friccius H; Boshell M; Siegels-Hübenthal P; Rehbein A; Schlotz E; Pohla H; Schaudt K; Sansom D
Cell Immunol; 1995 Apr; 162(1):8-15. PubMed ID: 7704914
[TBL] [Abstract][Full Text] [Related]
9. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
10. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
Cardoso AA; Schultze JL; Boussiotis VA; Freeman GJ; Seamon MJ; Laszlo S; Billet A; Sallan SE; Gribben JG; Nadler LM
Blood; 1996 Jul; 88(1):41-8. PubMed ID: 8704200
[TBL] [Abstract][Full Text] [Related]
11. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
12. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
Otten HG; Bor B; Ververs C; Verdonck LF; De Boer M; De Gast GC
Immunology; 1996 Jun; 88(2):214-9. PubMed ID: 8690453
[TBL] [Abstract][Full Text] [Related]
14. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of regulatory T cells 1 is induced by CD2 costimulation.
Wakkach A; Cottrez F; Groux H
J Immunol; 2001 Sep; 167(6):3107-13. PubMed ID: 11544295
[TBL] [Abstract][Full Text] [Related]
16. The role of adhesion and costimulation molecules in graft-versus-host disease.
Schlegel PG
Acta Haematol; 1997; 97(1-2):105-17. PubMed ID: 8980616
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytes.
Schmittel A; Scheibenbogen C; Keilholz U
Scand J Immunol; 1995 Dec; 42(6):701-4. PubMed ID: 8552995
[TBL] [Abstract][Full Text] [Related]
19. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.
Boussiotis VA; Gribben JG; Freeman GJ; Nadler LM
Curr Opin Immunol; 1994 Oct; 6(5):797-807. PubMed ID: 7530013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
